04.08.14
Medrobotics Corp. has obtained CE mark approval for its Flex system, a robot-assisted flexible endoscopic platform for use in surgical procedures.
The Flex system is designed to provide a cost-effective, robot-assisted surgical platform that enables hospitals and surgeons expand their minimally invasive treatment options to more patients. Medrobotics said the Flex system lets physicians navigate the Flex endoscope around anatomical structures to hard-to-reach locations through a single access site, and then use the onboard high-definition vision system to precisely deploy a range of third party flexible surgical instruments.
The wristed 3-millimeter Flex instruments enable surgeons to operate in confined spaces. President and CEO Samuel F. Straface, Ph.D., said the Flex system is the first robot-assisted flexible endoscopic platform for use during surgical procedures. “The system enables surgeons to access and visualize hard-to-reach anatomical locations and deploy specially designed flexible surgical instruments to perform procedures,” he noted.
With CE mark, the company will initiate a limited launch of the product in select European markets. The firm is preparing for European commercialization of the Flex system in otolaryngology.
Medrobotics Corp. is a privately held company headquartered in Raynham, Mass. Its primary technology is the Flex system, which is designed to provide a platform for enhanced visualization and enable two-handed dexterity with compatible third-party instruments providing tactile feedback. The system is not yet available in the United States.
The Flex system is designed to provide a cost-effective, robot-assisted surgical platform that enables hospitals and surgeons expand their minimally invasive treatment options to more patients. Medrobotics said the Flex system lets physicians navigate the Flex endoscope around anatomical structures to hard-to-reach locations through a single access site, and then use the onboard high-definition vision system to precisely deploy a range of third party flexible surgical instruments.
The wristed 3-millimeter Flex instruments enable surgeons to operate in confined spaces. President and CEO Samuel F. Straface, Ph.D., said the Flex system is the first robot-assisted flexible endoscopic platform for use during surgical procedures. “The system enables surgeons to access and visualize hard-to-reach anatomical locations and deploy specially designed flexible surgical instruments to perform procedures,” he noted.
With CE mark, the company will initiate a limited launch of the product in select European markets. The firm is preparing for European commercialization of the Flex system in otolaryngology.
Medrobotics Corp. is a privately held company headquartered in Raynham, Mass. Its primary technology is the Flex system, which is designed to provide a platform for enhanced visualization and enable two-handed dexterity with compatible third-party instruments providing tactile feedback. The system is not yet available in the United States.